0005

Jiangsu Sihuan Bioengineering Co., Ltd. (000518)

Market Closed
16 Jun, 06:57
XSHE XSHE
¥
2. 69
+0.13
+5.08%
¥
2.75B Market Cap
- P/E Ratio
0.12% Div Yield
19,609,976 Volume
- Eps
¥ 2.56
Previous Close
Day Range
2.58 2.69
Year Range
1.72 3.99

Summary

000518 closed today higher at ¥2.69, an increase of 5.08% from yesterday's close, completing a monthly increase of 48.62% or ¥0.88. Over the past 12 months, 000518 stock gained 6.75%.
000518 is not paying dividends to its shareholders.
The last earnings report, released on May 21, 2025, missed the consensus estimates by -0.02%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
Want to track 000518 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000518 Chart

Jiangsu Sihuan Bioengineering Co., Ltd. (000518) FAQ

What is the stock price today?

The current price is ¥2.69.

On which exchange is it traded?

Jiangsu Sihuan Bioengineering Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000518.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.75B.

Has Jiangsu Sihuan Bioengineering Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Jiangsu Sihuan Bioengineering Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Yu Guo CEO
XSHE Exchange
CNE0000001P8 ISIN
China Country
277 Employees
- Last Dividend
26 Aug 2003 Last Split
26 Apr 1993 IPO Date

Overview

Jiangsu Sihuan Bioengineering Co., Ltd. is a prominent player in the pharmaceutical sector within China, recognized for its commitment to delivering innovative healthcare solutions since its inception in 1992. With its headquarters nestled in Jiangyin, China, the company has established itself as a formidable force in the development, production, and marketing of pharmaceutical products. Jiangsu Sihuan Bioengineering Co., Ltd. has expanded its horizons beyond its initial pharmaceutical endeavors to include activities in the agricultural sector, specifically focusing on the breeding and sales of flowers and seedlings, in addition to undertaking landscaping projects. This diversification underscores the company's versatility and its drive to explore different business avenues while maintaining its core focus on pharmaceutical advances.

Products and Services

The product lineup from Jiangsu Sihuan Bioengineering Co., Ltd. is marked by a blend of innovative pharmaceutical solutions and agricultural offerings:

  • Delusen: This flagship biotherapeutic drug stands out as the crown jewel in Jiangsu Sihuan's pharmaceutical range, targeting several forms of cancer, including kidney cancer, malignant melanoma, and cancerous chest and abdominal masses. Delusen represents the company's stride towards pioneering in the field of oncology, showcasing its commitment to combatting formidable diseases with cutting-edge biotechnology.
  • Xinde Lusheng: While the specific details of this product are not extensively described, its inclusion in the company's portfolio indicates Jiangsu Sihuan's dedication to broadening its pharmaceutical offerings, potentially addressing other critical areas of medical need.
  • Xin Lisheng: Similarly, Xin Lisheng contributes to the depth of Jiangsu Sihuan's product range. Although its precise application is not detailed, it underscores the company's continuous effort to innovate and expand its footprint in the healthcare industry.
  • Ring BO: Detailing of Ring BO's specific therapeutic use or composition is limited, but its listing among the company's products implies a varied approach to healthcare solutions, which may complement the therapeutic effects of the other drugs produced by Jiangsu Sihuan.
  • Breeding and Sales of Flowers and Seedlings: Diversifying beyond the pharmaceutical realm, Jiangsu Sihuan also engages in horticulture. The company capitalizes on the breeding and sales of flowers and seedlings, venturing into the agricultural sector with a focus on aesthetic and environmental contributions through landscaping projects.
  • Landscaping Projects: This service complements the agricultural aspect of the company, involving the planning, design, management, and nurturing of gardens and landscapes. These projects likely harness the company's expertise in botany, as suggested by its involvement in flower and seedling sales, to enhance communal, private, and public spaces.

Contact Information

Address: No. 6 Zhongfang
Phone: 86 510 8640 8558